How Much Did Lynx Raise?
Funding & Key Investors

Lynx, a medical data science platform focused on developing diagnostic and therapeutic solutions, has secured significant enterprise-level funding, with its total capital raised standing at $12M. The company recently announced a major strategic investment of $12M, underscoring its growth trajectory and market potential in the health tech sector. This latest financing round is expected to accelerate Lynx's mission to provide accessible research health data and foster innovation in medical solutions.

What is Lynx?

Lynx
SoftwareHealthcare SoftwareBusiness Services

Lynx.MD operates as a sophisticated medical data science platform, enabling researchers to access vital health data and facilitating the development of advanced diagnostic and therapeutic solutions. Based in Palo Alto, California, the company is positioned at the intersection of healthcare and data analytics, aiming to streamline the path from data insights to clinical applications. Its focus on data accessibility and solution development suggests a strategic approach to addressing unmet needs within the medical research community.

How much funding has Lynx raised?

Lynx has raised a total of $12M across 1 funding round:

2021

Angel/Seed

$12M

Angel/Seed (2021): $12M with participation from Amdocs, MizMaa, Triventures, New York Life Ventures, UpWest, and iAngels

Key Investors in Lynx

Amdocs

Amdocs Limited is a global provider of software and services for the communications, entertainment, and media industries, suggesting a strategic interest in data solutions that could extend to healthcare.

MizMaa

MizMaa Ventures is an early-stage venture capital firm specializing in deep-technology solutions, indicating a focus on innovative and scalable technologies like those developed by Lynx.

Triventures

Triventures is a global venture capital fund that invests in early-stage companies with breakthroughs in healthcare and data-driven technologies, aligning with Lynx's mission.

What's next for Lynx?

With the recent infusion of major strategic investment, Lynx is poised for significant expansion and further development of its platform capabilities. The substantial enterprise-level funding indicates a strong investor confidence in Lynx's business model and its potential to disrupt the medical data science landscape. This capital injection will likely fuel advancements in their technology, broaden their research collaborations, and enhance their market reach, positioning Lynx as a key player in the evolution of data-driven healthcare solutions. The company's trajectory suggests a move towards scaling its operations and solidifying its position in the competitive health tech market.

See full Lynx company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Engineering SoftwareSoftware
Engineering SoftwareSoftwareBusiness ServicesSoftware Testing
Healthcare SoftwareSoftwareEducationTraining
Healthcare SoftwareSoftwareManufacturingMedical Devices & EquipmentMobile App Development

Frequently Asked Questions Regarding Lynx Financial Insights

What are the most recent funding rounds that Lynx has completed, and what were the funding rounds?
Lynx has recently completed 1 funding rounds: Angel/Seed on Dec 13, 2021.
What is the total amount of funding Lynx has raised to date?
Lynx has raised a total of $12M in funding to date.
How many funding rounds has Lynx completed?
Lynx has completed 1 funding rounds.
How much funding did Lynx raise in its most recent funding round?
Lynx raised $12M in its most recent funding round.
Who are the lead investors in Lynx's latest funding round?
The lead investor in Lynx's latest funding round was Amdocs. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Lynx's history?
The largest funding round in Lynx's history was $12M.
See more information about Lynx